Advertisement
Loading...

Alpha Teknova, Inc.

TKNONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.51
$-0.21(-5.65%)
U.S. Market opens in 28h 22m

Alpha Teknova, Inc. Fundamental Analysis

Alpha Teknova, Inc. (TKNO) shows moderate financial fundamentals with a PE ratio of -11.08, profit margin of -41.07%, and ROE of -24.32%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 7.35%.

Key Strengths

PEG Ratio-0.24
Current Ratio4.59

Areas of Concern

ROE-24.32%
Operating Margin-39.02%
Cash Position2.29%
We analyze TKNO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -20.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-20.3/100

We analyze TKNO's fundamental strength across five key dimensions:

Efficiency Score

Weak

TKNO struggles to generate sufficient returns from assets.

ROA > 10%
-17.40%

Valuation Score

Excellent

TKNO trades at attractive valuation levels.

PE < 25
-11.08
PEG Ratio < 2
-0.24

Growth Score

Excellent

TKNO delivers strong and consistent growth momentum.

Revenue Growth > 5%
7.35%
EPS Growth > 10%
43.86%

Financial Health Score

Excellent

TKNO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.23
Current Ratio > 1
4.59

Profitability Score

Weak

TKNO struggles to sustain strong margins.

ROE > 15%
-2431.82%
Net Margin ≥ 15%
-41.07%
Positive Free Cash Flow
No

Key Financial Metrics

Is TKNO Expensive or Cheap?

P/E Ratio

TKNO trades at -11.08 times earnings. This suggests potential undervaluation.

-11.08

PEG Ratio

When adjusting for growth, TKNO's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values Alpha Teknova, Inc. at 2.93 times its book value. This may indicate undervaluation.

2.93

EV/EBITDA

Enterprise value stands at -18.05 times EBITDA. This is generally considered low.

-18.05

How Well Does TKNO Make Money?

Net Profit Margin

For every $100 in sales, Alpha Teknova, Inc. keeps $-41.07 as profit after all expenses.

-41.07%

Operating Margin

Core operations generate -39.02 in profit for every $100 in revenue, before interest and taxes.

-39.02%

ROE

Management delivers $-24.32 in profit for every $100 of shareholder equity.

-24.32%

ROA

Alpha Teknova, Inc. generates $-17.40 in profit for every $100 in assets, demonstrating efficient asset deployment.

-17.40%

Following the Money - Real Cash Generation

Operating Cash Flow

Alpha Teknova, Inc. generates limited operating cash flow of $-7.70M, signaling weaker underlying cash strength.

$-7.70M

Free Cash Flow

Alpha Teknova, Inc. generates weak or negative free cash flow of $-8.87M, restricting financial flexibility.

$-8.87M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

TKNO converts -4.70% of its market value into free cash.

-4.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.55

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.17

vs 25 benchmark

ROCE

Return on capital employed

-0.18

vs 25 benchmark

How TKNO Stacks Against Its Sector Peers

MetricTKNO ValueSector AveragePerformance
P/E Ratio-11.0828.62 Better (Cheaper)
ROE-24.32%783.00% Weak
Net Margin-41.07%-48181.00% (disorted) Weak
Debt/Equity0.230.39 Strong (Low Leverage)
Current Ratio4.594.12 Strong Liquidity
ROA-17.40%-21914.00% (disorted) Weak

TKNO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Alpha Teknova, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-48.89%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-290.84%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-227.39%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ